 MELBOURNE, Australia, Jan. 21, 2021 GLOBE NEWSWIRE -- Molecular diagnostics company Genetic Technologies Limited ASX: GTG; NASDAQ: GENE, Company, provides the following update to the market on further development on the COVID-19 serious disease risk Polygenic Risk Score Test COVID-19 PRS Test and expansion of the Companys offering to include Germline Testing division. 